Merck's last crack at salvaging a $2.5B jury verdict in hep C patent showdown is shot down by appeals court
In December 2013, Gilead announced the first pill that could cure hepatitis C. The same week, Idenix Pharmaceuticals announced it was suing Gilead for …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
